Analyst Reco. Dr. Reddy's Laboratories Limited Nyse

Equities

RDY

US2561352038

Market Closed - Nyse Other stock markets 01:30:02 17/07/2024 am IST			5-day change	1st Jan Change
78.47 ^USD	-2.45%		+1.02%	+12.78%

16/07	Asian Equities Traded in the US as American Depositary Receipts Move Modestly Higher in Tuesday Trading	MT
16/07	Indian Equities Achieve New Closing Highs on Tuesday, Led by Realty, FMCG Goods Stocks	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Dr. Reddy’s Laboratories’ Price Target to INR5,010 From INR5,040, Keeps at Underperform	08/05	MT
Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $80 From $75, Keeps Overweight Rating	29/01	MT
Jefferies Adjusts Dr. Reddy’s Laboratories’ Price Target to INR6,250 From INR6,330, Keeps at Buy	30/23/30	MT
Jefferies Adjusts Dr. Reddy Laboratories’ to INR6,300 From INR5,600, Keeps at Buy	27/23/27	MT
Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $70 From $67, Maintains Overweight Rating	01/23/01	MT
Nomura Adjusts Dr Reddy's Laboratories' Price Target to INR5,161 From INR5,552, Keeps at Buy	30/23/30	MT
Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $66 From $69, Reiterates Overweight Rating	25/22/25	MT
Barclays Adjusts Dr. Reddy's Laboratories' Price Target to $69 from $68, Maintains Overweight Rating	12/22/12	MT
Barclays Lowers Dr. Reddy's Laboratories' Price Target to $68 From $70, Maintains Overweight Rating	25/22/25	MT
Nomura Adjusts Dr. Reddy's Laboratories’ Price Target to 5,552 Indian Rupees From 5,856 Indian Rupees, Keeps at Buy	31/22/31	MT
Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $80 From $78, Maintains Overweight Rating	01/21/01	MT
Nomura Adjusts Dr Reddy's Laboratories' Price Target to 5,856 Indian Rupees From 5,619 Indian Rupees, Keeps at Buy	01/21/01	MT
DR REDDY LABORATORIES : Nomura Adjusts Dr. Reddy's Laboratories' Price Target to 5,619 Indian Rupees From 6,145 Indian Rupees, Keeps at Buy	29/21/29	MT
DR REDDY LABORATORIES' : Price Target From Nomura Raised to INR6,145 From INR5,065, Buy Rating Maintained	18/21/18	MT
DR REDDY LABORATORIES : Nomura Adjusts Dr. Reddy's Laboratories' Price Target to 6,145 Indian Rupees From 5,065 Indian Rupees, Keeps at Buy	18/21/18	MT
-ANALYST ACTIONS : Nomura Upgrades Dr. Reddy's Laboratories to Buy From Neutral, Cuts Price Target to INR5,065 From INR5,165	22/21/22	MT
DR REDDY LABORATORIES : Nomura Upgrades Dr Reddy's Laboratories to Buy From Neutral, Adjusts Price Target to 5,065 Indian Rupees From 5,165 Indian Rupees	22/21/22	MT
DR REDDY LABORATORIES : Barclays Upgrades Dr. Reddy's Laboratories to Overweight From Equal-Weight, Adjusts Price Target to $70 From $56	02/21/02	MT
DR REDDY LABORATORIES : Nomura Downgrades Dr Reddy's Laboratories to Neutral From Buy, Adjusts Price Target to 5,165 Indian Rupees From 6,066 Indian Rupees	01/21/01	MT
Dr Reddy Laboratories : Intimation of Credit Rating – May 01, 2020	05/20/05	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Dr. Reddy's Laboratories Limited Nyse

Equities

RDY

US2561352038

Analyst Reco.

Filters